Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Acute Kidney Injury | 8 | 2013 | 312 | 1.260 |
Why?
|
Kidney | 8 | 2013 | 1146 | 1.090 |
Why?
|
Hypertension | 2 | 2019 | 744 | 0.880 |
Why?
|
Tumor Necrosis Factor-alpha | 5 | 2013 | 699 | 0.870 |
Why?
|
Endotoxemia | 3 | 2012 | 18 | 0.870 |
Why?
|
Kidney Glomerulus | 6 | 2013 | 122 | 0.690 |
Why?
|
Thrombotic Microangiopathies | 1 | 2019 | 21 | 0.690 |
Why?
|
Apolipoprotein L1 | 1 | 2019 | 7 | 0.690 |
Why?
|
Tetrazoles | 1 | 2019 | 24 | 0.680 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2019 | 46 | 0.670 |
Why?
|
Complement Activation | 6 | 2015 | 81 | 0.670 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2019 | 126 | 0.650 |
Why?
|
Benzimidazoles | 1 | 2019 | 111 | 0.640 |
Why?
|
RNA, Small Interfering | 2 | 2019 | 557 | 0.620 |
Why?
|
Colistin | 2 | 2017 | 7 | 0.590 |
Why?
|
Lipopolysaccharides | 7 | 2013 | 293 | 0.580 |
Why?
|
Antihypertensive Agents | 1 | 2019 | 249 | 0.560 |
Why?
|
Pharmacogenetics | 2 | 2019 | 443 | 0.520 |
Why?
|
Nephritis | 2 | 2018 | 17 | 0.490 |
Why?
|
Cell Cycle Checkpoints | 1 | 2013 | 66 | 0.440 |
Why?
|
Urothelium | 1 | 2013 | 71 | 0.430 |
Why?
|
Mice, Inbred C57BL | 12 | 2013 | 3211 | 0.430 |
Why?
|
Sepsis | 3 | 2013 | 320 | 0.430 |
Why?
|
Tight Junction Proteins | 1 | 2012 | 14 | 0.420 |
Why?
|
Tight Junctions | 2 | 2015 | 150 | 0.410 |
Why?
|
Endothelial Cells | 3 | 2015 | 459 | 0.390 |
Why?
|
Intercellular Adhesion Molecule-1 | 2 | 2009 | 73 | 0.380 |
Why?
|
Caspase 8 | 1 | 2009 | 34 | 0.340 |
Why?
|
Myosin-Light-Chain Kinase | 1 | 2009 | 41 | 0.330 |
Why?
|
rho GTP-Binding Proteins | 1 | 2009 | 55 | 0.330 |
Why?
|
Mice | 19 | 2014 | 11743 | 0.320 |
Why?
|
Kidney Transplantation | 4 | 2019 | 850 | 0.320 |
Why?
|
Polymorphism, Single Nucleotide | 4 | 2019 | 2399 | 0.260 |
Why?
|
Receptors, Cell Surface | 2 | 2004 | 289 | 0.250 |
Why?
|
Complement C5a | 2 | 2015 | 24 | 0.250 |
Why?
|
Animals | 22 | 2014 | 27338 | 0.250 |
Why?
|
Kidney Tubules | 3 | 2013 | 92 | 0.250 |
Why?
|
Glomerulonephritis, Membranous | 1 | 2005 | 23 | 0.250 |
Why?
|
Caspases | 1 | 2004 | 155 | 0.240 |
Why?
|
Membrane Glycoproteins | 2 | 2004 | 432 | 0.240 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 3 | 2013 | 43 | 0.240 |
Why?
|
Complement C3 | 4 | 2002 | 58 | 0.220 |
Why?
|
Apoptosis | 6 | 2009 | 1717 | 0.220 |
Why?
|
Graft Rejection | 2 | 2019 | 1069 | 0.210 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2002 | 90 | 0.200 |
Why?
|
Receptors, Complement | 4 | 2002 | 46 | 0.190 |
Why?
|
Disease Models, Animal | 5 | 2014 | 2363 | 0.190 |
Why?
|
Glomerulonephritis | 1 | 2001 | 76 | 0.190 |
Why?
|
Lipopolysaccharide Receptors | 1 | 2000 | 23 | 0.180 |
Why?
|
Male | 15 | 2019 | 42347 | 0.180 |
Why?
|
Antigens, CD | 1 | 2002 | 466 | 0.180 |
Why?
|
Biological Variation, Individual | 1 | 2019 | 7 | 0.170 |
Why?
|
Blood-Brain Barrier | 3 | 2015 | 74 | 0.170 |
Why?
|
Gene Targeting | 1 | 2019 | 73 | 0.170 |
Why?
|
Biphenyl Compounds | 1 | 2019 | 59 | 0.170 |
Why?
|
Pharmacogenomic Variants | 1 | 2019 | 42 | 0.170 |
Why?
|
Fatal Outcome | 1 | 2019 | 299 | 0.160 |
Why?
|
Drug Monitoring | 1 | 2019 | 119 | 0.160 |
Why?
|
Calcium Channel Blockers | 1 | 2019 | 121 | 0.160 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2019 | 105 | 0.160 |
Why?
|
Albuminuria | 2 | 2013 | 48 | 0.160 |
Why?
|
Bowman Capsule | 1 | 2018 | 6 | 0.160 |
Why?
|
Drug Delivery Systems | 1 | 2019 | 179 | 0.160 |
Why?
|
Signal Transduction | 1 | 2009 | 3376 | 0.150 |
Why?
|
Tacrolimus | 1 | 2019 | 369 | 0.150 |
Why?
|
Gene Expression Profiling | 2 | 2014 | 1429 | 0.150 |
Why?
|
Chronic Disease | 2 | 2019 | 948 | 0.150 |
Why?
|
Renal Dialysis | 2 | 2018 | 335 | 0.150 |
Why?
|
Complement Inactivator Proteins | 3 | 2002 | 27 | 0.150 |
Why?
|
Immunity, Cellular | 1 | 2018 | 178 | 0.150 |
Why?
|
Cysteine Proteinase Inhibitors | 2 | 2009 | 53 | 0.140 |
Why?
|
Mice, Knockout | 5 | 2013 | 1990 | 0.140 |
Why?
|
Neutrophil Infiltration | 2 | 2009 | 28 | 0.140 |
Why?
|
Income | 1 | 2017 | 83 | 0.140 |
Why?
|
Lupus Erythematosus, Systemic | 2 | 2015 | 210 | 0.140 |
Why?
|
Genome-Wide Association Study | 3 | 2019 | 1670 | 0.130 |
Why?
|
Neutrophils | 4 | 2007 | 308 | 0.130 |
Why?
|
Sequence Analysis, DNA | 1 | 2019 | 866 | 0.130 |
Why?
|
Minority Groups | 1 | 2017 | 145 | 0.130 |
Why?
|
Enzyme Activation | 2 | 2009 | 698 | 0.130 |
Why?
|
Receptor, Anaphylatoxin C5a | 1 | 2015 | 21 | 0.130 |
Why?
|
T-Lymphocytes | 2 | 2018 | 1224 | 0.130 |
Why?
|
Gene Expression Regulation | 2 | 2014 | 1975 | 0.120 |
Why?
|
Blood Pressure | 1 | 2019 | 900 | 0.120 |
Why?
|
Genotype | 1 | 2019 | 1848 | 0.120 |
Why?
|
Immunosuppressive Agents | 1 | 2019 | 975 | 0.120 |
Why?
|
Homeodomain Proteins | 2 | 2017 | 556 | 0.120 |
Why?
|
Active Transport, Cell Nucleus | 2 | 2015 | 78 | 0.110 |
Why?
|
Repressor Proteins | 1 | 2017 | 423 | 0.110 |
Why?
|
Galectin 3 | 1 | 2013 | 17 | 0.110 |
Why?
|
Proliferating Cell Nuclear Antigen | 1 | 2013 | 67 | 0.110 |
Why?
|
In Situ Nick-End Labeling | 1 | 2013 | 122 | 0.110 |
Why?
|
Communication | 1 | 2017 | 459 | 0.110 |
Why?
|
Brain | 3 | 2015 | 2281 | 0.110 |
Why?
|
Adenine Nucleotides | 1 | 2013 | 63 | 0.110 |
Why?
|
Health Services Accessibility | 1 | 2017 | 427 | 0.110 |
Why?
|
Arabinonucleosides | 1 | 2013 | 39 | 0.110 |
Why?
|
Cells, Cultured | 4 | 2015 | 2880 | 0.110 |
Why?
|
Necrosis | 1 | 2013 | 209 | 0.110 |
Why?
|
Immunoglobulin G | 4 | 2002 | 465 | 0.110 |
Why?
|
Kidney Failure, Chronic | 1 | 2017 | 414 | 0.110 |
Why?
|
Genes | 1 | 2013 | 305 | 0.100 |
Why?
|
Kidney Tubules, Distal | 1 | 2012 | 19 | 0.100 |
Why?
|
Cluster Analysis | 1 | 2013 | 371 | 0.100 |
Why?
|
Humans | 10 | 2019 | 89222 | 0.100 |
Why?
|
Cytosine | 1 | 2013 | 128 | 0.100 |
Why?
|
Transcription Factor RelA | 2 | 2009 | 49 | 0.100 |
Why?
|
Body Weight | 1 | 2013 | 452 | 0.100 |
Why?
|
Physician-Patient Relations | 1 | 2017 | 625 | 0.100 |
Why?
|
Anti-Bacterial Agents | 1 | 2017 | 787 | 0.100 |
Why?
|
Female | 6 | 2019 | 46118 | 0.090 |
Why?
|
Reperfusion Injury | 2 | 2002 | 141 | 0.090 |
Why?
|
Acute Disease | 1 | 2012 | 841 | 0.090 |
Why?
|
Cell Line | 4 | 2017 | 2495 | 0.090 |
Why?
|
Treatment Outcome | 2 | 2019 | 8227 | 0.090 |
Why?
|
MicroRNAs | 1 | 2014 | 551 | 0.090 |
Why?
|
NF-KappaB Inhibitor alpha | 1 | 2009 | 42 | 0.080 |
Why?
|
Myosin Light Chains | 1 | 2009 | 29 | 0.080 |
Why?
|
Caspase Inhibitors | 1 | 2009 | 33 | 0.080 |
Why?
|
NF-kappa B | 2 | 2015 | 466 | 0.080 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2009 | 56 | 0.080 |
Why?
|
I-kappa B Proteins | 1 | 2009 | 54 | 0.080 |
Why?
|
Mice, Transgenic | 4 | 2007 | 1574 | 0.080 |
Why?
|
Receptors, Complement 3b | 4 | 2002 | 39 | 0.080 |
Why?
|
Epigenesis, Genetic | 1 | 2013 | 507 | 0.080 |
Why?
|
Transcription Factors | 1 | 2017 | 1652 | 0.080 |
Why?
|
rhoA GTP-Binding Protein | 1 | 2009 | 85 | 0.080 |
Why?
|
Antineoplastic Agents | 1 | 2019 | 2412 | 0.080 |
Why?
|
Clusterin | 1 | 2007 | 13 | 0.080 |
Why?
|
bcl-X Protein | 1 | 2007 | 54 | 0.080 |
Why?
|
Cell Adhesion | 1 | 2009 | 426 | 0.080 |
Why?
|
Brain Diseases, Metabolic | 1 | 2007 | 8 | 0.070 |
Why?
|
Aged | 3 | 2019 | 19128 | 0.070 |
Why?
|
CD18 Antigens | 1 | 2007 | 22 | 0.070 |
Why?
|
Endotoxins | 1 | 2007 | 36 | 0.070 |
Why?
|
Adult | 4 | 2019 | 26559 | 0.070 |
Why?
|
Kidney Diseases | 2 | 2007 | 319 | 0.070 |
Why?
|
Encephalitis | 1 | 2007 | 104 | 0.070 |
Why?
|
Reproducibility of Results | 1 | 2013 | 2754 | 0.070 |
Why?
|
Nitric Oxide Synthase Type II | 2 | 2007 | 88 | 0.070 |
Why?
|
Phosphorylation | 1 | 2009 | 1130 | 0.070 |
Why?
|
Middle Aged | 3 | 2019 | 25929 | 0.060 |
Why?
|
Complement System Proteins | 2 | 2002 | 83 | 0.060 |
Why?
|
Amino Acid Chloromethyl Ketones | 1 | 2004 | 25 | 0.060 |
Why?
|
Gene Expression | 3 | 2013 | 1310 | 0.060 |
Why?
|
Protein Kinase Inhibitors | 1 | 2009 | 604 | 0.060 |
Why?
|
C-Reactive Protein | 1 | 2005 | 192 | 0.060 |
Why?
|
Injections, Intraperitoneal | 1 | 2004 | 101 | 0.060 |
Why?
|
Cell Movement | 1 | 2007 | 783 | 0.060 |
Why?
|
Toll-Like Receptor 4 | 1 | 2004 | 91 | 0.060 |
Why?
|
Mice, Inbred C3H | 1 | 2004 | 371 | 0.060 |
Why?
|
Toll-Like Receptors | 1 | 2004 | 92 | 0.050 |
Why?
|
Rats | 4 | 2002 | 4041 | 0.050 |
Why?
|
Glomerular Mesangium | 1 | 2002 | 18 | 0.050 |
Why?
|
CD55 Antigens | 1 | 2002 | 21 | 0.050 |
Why?
|
Endothelium, Vascular | 2 | 2002 | 433 | 0.050 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 1 | 2002 | 20 | 0.050 |
Why?
|
Purpura, Thrombotic Thrombocytopenic | 1 | 2002 | 18 | 0.050 |
Why?
|
Species Specificity | 1 | 2004 | 684 | 0.050 |
Why?
|
Nitric Oxide Synthase | 1 | 2002 | 126 | 0.050 |
Why?
|
Complement C5b | 1 | 2001 | 2 | 0.050 |
Why?
|
Heymann Nephritis Antigenic Complex | 1 | 2001 | 3 | 0.050 |
Why?
|
Complement C3b | 1 | 2001 | 5 | 0.050 |
Why?
|
Complement C3d | 1 | 2001 | 6 | 0.050 |
Why?
|
CD59 Antigens | 1 | 2001 | 17 | 0.050 |
Why?
|
Complement C5 | 1 | 2001 | 14 | 0.050 |
Why?
|
Transgenes | 1 | 2002 | 185 | 0.050 |
Why?
|
Immunization, Passive | 1 | 2001 | 71 | 0.050 |
Why?
|
Antigens, Surface | 1 | 2001 | 103 | 0.050 |
Why?
|
Astrocytes | 2 | 2015 | 141 | 0.050 |
Why?
|
Complement Factor H | 1 | 2001 | 34 | 0.050 |
Why?
|
Renal Circulation | 1 | 2001 | 48 | 0.050 |
Why?
|
Lupus Nephritis | 1 | 2002 | 77 | 0.050 |
Why?
|
Blood Platelets | 1 | 2001 | 150 | 0.050 |
Why?
|
Receptors, Immunologic | 1 | 2001 | 135 | 0.050 |
Why?
|
Immunity, Innate | 1 | 2004 | 429 | 0.040 |
Why?
|
Time Factors | 1 | 2009 | 5336 | 0.040 |
Why?
|
Datasets as Topic | 1 | 2019 | 75 | 0.040 |
Why?
|
Ischemia | 1 | 2001 | 251 | 0.040 |
Why?
|
Recombinant Fusion Proteins | 1 | 2000 | 565 | 0.040 |
Why?
|
Risk Factors | 2 | 2019 | 5490 | 0.040 |
Why?
|
Allografts | 1 | 2018 | 181 | 0.040 |
Why?
|
Drug Resistance | 1 | 2017 | 232 | 0.030 |
Why?
|
Junctional Adhesion Molecules | 1 | 2015 | 3 | 0.030 |
Why?
|
Claudin-5 | 1 | 2015 | 5 | 0.030 |
Why?
|
Graft Survival | 1 | 2019 | 900 | 0.030 |
Why?
|
United States | 2 | 2019 | 6975 | 0.030 |
Why?
|
Antibodies, Monoclonal | 1 | 2002 | 1410 | 0.030 |
Why?
|
Poverty | 1 | 2017 | 180 | 0.030 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2015 | 68 | 0.030 |
Why?
|
Zonula Occludens-1 Protein | 1 | 2015 | 70 | 0.030 |
Why?
|
Electric Impedance | 1 | 2015 | 110 | 0.030 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2015 | 123 | 0.030 |
Why?
|
Health Status | 1 | 2017 | 371 | 0.030 |
Why?
|
Preoperative Care | 1 | 2017 | 396 | 0.030 |
Why?
|
Permeability | 1 | 2014 | 137 | 0.030 |
Why?
|
Socioeconomic Factors | 1 | 2017 | 585 | 0.030 |
Why?
|
Biopsy | 1 | 2018 | 1183 | 0.030 |
Why?
|
Protein Transport | 1 | 2015 | 421 | 0.030 |
Why?
|
Disease Progression | 1 | 2018 | 1488 | 0.030 |
Why?
|
Actin Cytoskeleton | 1 | 2015 | 196 | 0.030 |
Why?
|
HapMap Project | 1 | 2013 | 47 | 0.030 |
Why?
|
Adolescent | 2 | 2017 | 9247 | 0.030 |
Why?
|
Chicago | 1 | 2018 | 1424 | 0.030 |
Why?
|
Comorbidity | 1 | 2017 | 948 | 0.030 |
Why?
|
Predictive Value of Tests | 1 | 2018 | 1721 | 0.030 |
Why?
|
Quantitative Trait Loci | 1 | 2017 | 607 | 0.030 |
Why?
|
Thiazides | 1 | 2012 | 16 | 0.030 |
Why?
|
Sodium Chloride Symporters | 1 | 2012 | 13 | 0.030 |
Why?
|
Follow-Up Studies | 1 | 2019 | 3661 | 0.030 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2013 | 198 | 0.030 |
Why?
|
Healthcare Disparities | 1 | 2017 | 413 | 0.030 |
Why?
|
Linkage Disequilibrium | 1 | 2013 | 477 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2013 | 313 | 0.020 |
Why?
|
Models, Animal | 1 | 2012 | 276 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2013 | 639 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2017 | 2553 | 0.020 |
Why?
|
Cohort Studies | 1 | 2017 | 2866 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2013 | 681 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 2 | 2002 | 1237 | 0.020 |
Why?
|
Surveys and Questionnaires | 1 | 2017 | 2616 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2013 | 726 | 0.020 |
Why?
|
Quality of Life | 1 | 2017 | 1665 | 0.020 |
Why?
|
RNA, Messenger | 2 | 2007 | 2012 | 0.020 |
Why?
|
Prospective Studies | 1 | 2017 | 4281 | 0.020 |
Why?
|
Cytochromes c | 1 | 2007 | 27 | 0.020 |
Why?
|
bcl-2-Associated X Protein | 1 | 2007 | 46 | 0.020 |
Why?
|
I-kappa B Kinase | 1 | 2007 | 41 | 0.020 |
Why?
|
Serum Albumin, Bovine | 1 | 2007 | 45 | 0.020 |
Why?
|
MAP Kinase Kinase Kinases | 1 | 2007 | 42 | 0.020 |
Why?
|
Transcription Factor AP-1 | 1 | 2007 | 65 | 0.020 |
Why?
|
Aquaporin 4 | 1 | 2007 | 8 | 0.020 |
Why?
|
Gliosis | 1 | 2007 | 35 | 0.020 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2007 | 38 | 0.020 |
Why?
|
Brain Edema | 1 | 2007 | 58 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2007 | 153 | 0.020 |
Why?
|
Phenotype | 1 | 2013 | 2439 | 0.020 |
Why?
|
Genetic Variation | 1 | 2013 | 1373 | 0.020 |
Why?
|
Young Adult | 1 | 2017 | 6301 | 0.020 |
Why?
|
Child | 1 | 2015 | 7158 | 0.010 |
Why?
|
Nephrosis | 1 | 2002 | 3 | 0.010 |
Why?
|
Microscopy, Immunoelectron | 1 | 2002 | 29 | 0.010 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 2002 | 68 | 0.010 |
Why?
|
Hemolytic-Uremic Syndrome | 1 | 2002 | 9 | 0.010 |
Why?
|
Mice, Inbred MRL lpr | 1 | 2002 | 36 | 0.010 |
Why?
|
Anemia, Hemolytic | 1 | 2002 | 19 | 0.010 |
Why?
|
Cell Polarity | 1 | 2002 | 116 | 0.010 |
Why?
|
Erythrocytes | 1 | 2002 | 254 | 0.010 |
Why?
|
Receptors, Complement 3d | 1 | 2001 | 14 | 0.010 |
Why?
|
Staining and Labeling | 1 | 2001 | 168 | 0.010 |
Why?
|
Antibodies | 1 | 2002 | 353 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2001 | 418 | 0.010 |
Why?
|
DNA Primers | 1 | 2001 | 543 | 0.010 |
Why?
|
Solubility | 1 | 2001 | 179 | 0.010 |
Why?
|
Autoimmune Diseases | 1 | 2002 | 249 | 0.010 |
Why?
|
Autoantibodies | 1 | 2001 | 268 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2002 | 688 | 0.010 |
Why?
|
Survival Analysis | 1 | 2002 | 1534 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2001 | 2062 | 0.010 |
Why?
|
Base Sequence | 1 | 2001 | 2327 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 2002 | 739 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2001 | 3027 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2002 | 1241 | 0.010 |
Why?
|